Key takeaways
- The symptoms of anxiety in women in their 40s and 50s could be a sign of perimenopause, not generalized anxiety disorder.
- Misdiagnosis can lead to improper treatment, causing frustration and a delay in receiving the correct care for hormonal imbalances.
- A systematic change in healthcare is needed to properly recognize and address perimenopausal symptoms, aiding in a more holistic approach.
= Sharing personal journeys and advocating for better diagnostic practices can challenge the status quo and help others who may be facing similar issues.
Is It Anxiety—or Perimenopause?
“I feel anxious all the time, but I know I’m not really anxious.” This is a refrain heard in countless doctor’s offices and kitchen conversations among women in their 40s and early 50s.
In recent years, many women have reported unexplained anxiety, racing thoughts, heart palpitations, sleep disturbances, and mood volatility—only to be told they are experiencing generalized anxiety disorder. But what if this is not simply anxiety? For many, it may actually be perimenopause expressing itself through the nervous system.¹,⁴
The medical community has only recently begun to acknowledge the overlap between anxiety disorders and the hormonal fluctuations of perimenopause. As a result, many women are prescribed antidepressants or anti-anxiety medications, sometimes for years, when a more accurate diagnosis could focus on the hormonal shifts involved. Incorrect labeling can delay proper care, create frustration, and leave women feeling misunderstood—not only by health professionals, but also by family and friends who see only the outward signs.¹
The Overlap Between Hormones and Mental Health
Perimenopause is the transitional phase before menopause, often beginning as early as the mid-to-late 30s, though more commonly in the 40s. It can last anywhere from four to ten years. Estrogen and progesterone, the key hormonal players, are closely involved in regulating neurotransmitters such as serotonin and gamma-aminobutyric acid (GABA), which are central to mood stabilization and relaxation.¹,⁴
During perimenopause, these hormone levels become unpredictable, leading to neurotransmitter changes that may present as:
● Sudden anxiety or panic attacks in women with no prior history
● Insomnia or disrupted sleep cycles
● Mood swings, irritability, or depressive symptoms
● Difficulty concentrating or “brain fog”
A 2021 study published in Menopause found that nearly 58% of women going through perimenopause reported increased anxiety, compared with 33% of premenopausal women.² Yet, medical protocols do not always screen for perimenopausal symptoms before assigning a psychiatric diagnosis. This diagnostic gap may explain why so many women feel their concerns are dismissed.
Why Are Women Being Misdiagnosed?
The healthcare system’s historic focus on reproductive symptoms—such as irregular periods or hot flashes—means that psychological or neurological complaints are often separated from gynecologic evaluation. Women are frequently offered psychotropic medications before hormone evaluation, despite strong evidence linking hormonal fluctuations to mood disorders during this period.¹
According to surveys from the North American Menopause Society (NAMS), the average time from onset of perimenopausal symptoms to diagnosis can exceed two years in many cases.¹ During that time, women often cycle through multiple general practitioners, mental health providers, and specialists. The result is often unnecessary medications, delayed hormone support, and a lack of clarity.
Systemic gender bias also contributes to the problem. Research published in the BMJ has shown that women’s physical symptoms are more likely to be attributed to psychological causes than men’s, even when similar symptoms are presented.³ This means that perimenopausal symptoms—already difficult to measure and explain—are particularly vulnerable to “it’s all in your head” messaging.
The Ripple Effects of Misdiagnosis
The consequences of this misdiagnosis are significant. Women may be deprived of personalized care, and the emotional burden can be substantial. Many report losing trust in the medical system, feeling isolated in their experience, or second-guessing their own bodies. Relationships may also suffer if family, friends, or employers interpret symptoms as personal weakness, stress, or “just anxiety.”
Access to targeted interventions—such as hormone support, nutritional changes, cognitive behavioral strategies for perimenopausal women, or improved sleep hygiene—is often delayed. Instead, the focus may remain on psychiatric medications with inconsistent or disappointing results.
There is also an economic impact. Work productivity may decline, healthcare costs rise due to repeated appointments, and women may spend heavily on alternative therapies without clear direction. The ripple effect is not only personal—it is societal.
Moving Toward Improved Awareness and Understanding
It is time for a broader cultural and clinical shift. Open and validated conversations about perimenopause must become normal in communities, workplaces, and especially in doctors’ offices. These conversations should include:
● Detailed health histories that account for age, menstrual patterns, and changing symptoms across months or years
● Increased training for healthcare professionals on the neuropsychiatric presentation of perimenopause
● Inclusion of screening questions about hormonal milestones with every new report of anxiety or mood symptoms in women aged 35 and older
● Integration of gynecologic and mental health care to support a more holistic approach
Community support is equally important. When women share their experiences—including both successes and setbacks—it helps reduce isolation and stigma while replacing it with solidarity and practical information. Online forums, local support groups, and workplace wellness initiatives all have a role to play.
If you have ever felt dismissed by a diagnosis that did not fit, your story matters. It may help countless others and can support advocacy for better diagnostic pathways. The tools and knowledge already exist, but meaningful change depends on the willingness to listen and the courage to speak openly.
This article is for informational purposes only and is not medical advice. Always consult your healthcare provider regarding any questions or concerns about your health or treatment options.
References
1. North American Menopause Society. Anxiety and menopause: managing perimenopausal symptoms. Accessed April 26, 2026. https://www.menopause.org/for- women/ menopauseflashes/anxiety-and-menopause
2. Bromberger JT, Epperson CN. Prevalence of anxiety and depressive symptoms during the menopausal transition. Menopause. 2021;28(4):1-8.
3. Samulowitz A, Gremyr I, Eriksson E, Hensing G. “Brave men” and “emotional women”: a theory-guided literature review on gender bias in health care and gendered norms toward patients with chronic pain. BMJ. 2020;371:m4029. doi:10.1136/bmj.m4029
4. Harvard Health Publishing. Perimenopause: rocky road to menopause. Accessed April 26, 2026. https://www.health.harvard.edu/womens-health/perimenopause-rocky -road-to-menopause